Clinical Study
Efficacy and Safety of a Novel Herbal Medicine in the Treatment of Irritable Bowel Syndrome: A Randomized Double-Blinded Clinical Trial
Table 1
Baseline characteristics and IBS-related summary measures of randomized patients.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IBS: irritable bowel syndrome; IBS-SSS: IBS Symptom Severity Scale; IBS-D: diarrhea-predominant IBS; IBS-C: constipation-predominant IBS; IBS-M/U: IBS with mixed symptoms/unsubtyped IBS; s.d.: standard deviation. |